Thorne entered into a Master Clinical Study Agreement with
Mayo Clinic in August 2014 to conduct a series of randomized
double-blind placebo-controlled clinical trials on several
nutritional supplements. The studies are designed to test
the safety and efficacy of a range of single compounds from
natural sources, plant extracts with complex molecular
attributes, and complex nutritional products formulated to
address specific nutritional needs.
The primary focus has been on testing materials that are considered GRAS (Generally Recognized as Safe) within the FDA designation, and to emphasize the understanding of mechanism of action, safety, pharmacokinetics, and optimal use for these products. Thorne also provides reliable, relevant health information from Mayo Clinic to the general public.